Mitula Pharmaceuticals Private Limited
About Mitula Pharmaceuticals Private Limited
Data last updated:
Mitula Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 26 February 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21009MH2023PTC398371. Its GSTIN is 24AAQCM6068D1ZA (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saritadevi Mittal and Kamal Narsilal Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1108 Sureshwari Techno IT Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.55 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹8.57 Lakh (net margin -68.2%) and EBITDA of -₹8.08 Lakh (EBITDA margin -64.3%).
Company details
Contact details
Mitula Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address1108 Sureshwari Techno IT Park Premises Chs, Link Road Nr Eskay Resorts, Mumbai, Maharashtra, India – 400092
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mitula Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mitula Pharmaceuticals Private Limited, buy the company report.
Financials of Mitula Pharmaceuticals Private Limited
FY 2025 filings availableMitula Pharmaceuticals Private Limited reported revenue of ₹12.55 Lakh (down 54% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 54% in the latest year. EBITDA fell 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹8.08 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹8.57 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -64.3% | ||
| Net Profit Margin | -68.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mitula Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mitula Pharmaceuticals Private Limited
Mitula Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saritadevi Mittal | Director | 26 Feb 2023 | 3 Years 7 Months | Current |
| Kamal Narsilal Mittal | Director | 26 Feb 2023 | 3 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Mitula Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mitula Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mitula Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAQCM6068D1ZA | Gujarat | Active | 24 Apr 2023 |
To see the full GST registrations and return filing status of Mitula Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mitula Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Kamal Narsilal Mittal was appointed as Director on 26 Feb 2023.
Frequently asked questions
Mitula Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 26 February 2023 (3+ years old) and is registered under CIN U21009MH2023PTC398371.
Mitula Pharmaceuticals has 2 current directors:
- Saritadevi Mittal - Director
- Kamal Narsilal Mittal - Director
The latest financial statements of Mitula Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Mitula Pharmaceuticals is 24AAQCM6068D1ZA, registered in Gujarat.
The CIN (Corporate Identification Number) of Mitula Pharmaceuticals is U21009MH2023PTC398371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mitula Pharmaceuticals was incorporated on 26 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Kamal Narsilal Mittal was appointed as Director on 26 Feb 2023. Saritadevi Mittal was appointed as Director on 26 Feb 2023.
The registered office of Mitula Pharmaceuticals is at 1108 Sureshwari Techno IT Park Premises Chs, Link Road Nr Eskay Resorts, Mumbai, Maharashtra, India – 400092.
Mitula Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Mitula Pharmaceuticals can be reached at its registered office: 1108 Sureshwari Techno IT Park Premises Chs, Link Road Nr Eskay Resorts, Mumbai, Maharashtra, India – 400092.